Inventor
HAY BRUCE A
US26 patents
⚠️ This page may combine multiple inventors who share the name “HAY BRUCE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NAMMI THERAPEUTICS INC
8 patentsUS11896646B2Feb 13, 2024
Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC1 citations70
US11744874B2Sep 5, 2023
Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC1 citations70
US11679141B2Jun 20, 2023
Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC1 citations70
US12311010B2May 27, 2025
Formulated and/or co-formulated liposome compositions containing toll-like receptor(“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC0 citations59
US12286403B2Apr 29, 2025
Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC0 citations59
US12059470B2Aug 13, 2024
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC0 citations59
US11833209B2Dec 5, 2023
Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC0 citations59
US11801304B2Oct 31, 2023
Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof
NAMMI THERAPEUTICS INC1 citations59
PFIZER
6 patentsUS5013571AMay 7, 1991
Methods for making tetrahydroisoalpha and hexahydroisoalpha acids
PFIZER128 citations97
US6720330B2Apr 13, 2004
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
PFIZER25 citations91
US6696418B1Feb 24, 2004
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
PFIZER18 citations82
US6495589B2Dec 17, 2002
Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
PFIZER18 citations82
US5013572AMay 7, 1991
Steam stripping of odor forming impurities from hop flavors
PFIZER12 citations73
US4851548AJul 25, 1989
Superior catalysts for preparation of 3-amino-2,2,4,4-tetramethylthietane via the Leuckart reaction
PFIZER3 citations62
CALIFORNIA INST OF TECHN
6 patentsUS10570200B2Feb 25, 2020
Antibody-mediated immunocontraception
CALIFORNIA INST OF TECHN5 citations73
US12157883B2Dec 3, 2024
DNA sequence modification-based gene drive
CALIFORNIA INST OF TECHN2 citations67
US11965172B2Apr 23, 2024
DNA sequence modification-based gene drive
CALIFORNIA INST OF TECHN2 citations67
US10966414B2Apr 6, 2021
Population control using engineered translocations
CALIFORNIA INST OF TECHN3 citations65
US12213468B2Feb 4, 2025
Population control using engineered translocations
CALIFORNIA INST OF TECHN1 citations57
US12577583B2Mar 17, 2026
DNA sequence modification-based gene drive
CALIFORNIA INST OF TECHN0 citations56
NANOPHARMACEUTICALS LLC
3 patentsUS10961204B1Mar 30, 2021
Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
NANOPHARMACEUTICALS LLC4 citations73
US11186551B2Nov 30, 2021
Composition of scalable thyrointegrin antagonists with improved retention in tumors
NANOPHARMACEUTICALS LLC0 citations62
US11723888B2Aug 15, 2023
Polymer conjugated thyrointegrin antagonists
NANOPHARMACEUTICALS LLC0 citations56